Christopher A. LeClair

919 total citations
20 papers, 311 citations indexed

About

Christopher A. LeClair is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, Christopher A. LeClair has authored 20 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Spectroscopy. Recurrent topics in Christopher A. LeClair's work include Ubiquitin and proteasome pathways (4 papers), Chemical Synthesis and Analysis (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Christopher A. LeClair is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Chemical Synthesis and Analysis (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Christopher A. LeClair collaborates with scholars based in United States, Italy and Russia. Christopher A. LeClair's co-authors include Glenn J. McGarvey, Craig J. Thomas, Dingyin Tao, Anton Simeonov, Yuhong Fang, Ruili Huang, Menghang Xia, Matthew B. Boxer, David J. Maloney and Sam Michael and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Analytical Chemistry.

In The Last Decade

Christopher A. LeClair

20 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. LeClair United States 10 148 99 35 33 21 20 311
Allison M. Roberts United States 7 269 1.8× 130 1.3× 18 0.5× 23 0.7× 15 0.7× 7 345
Angela Wittelsberger United States 13 362 2.4× 122 1.2× 18 0.5× 48 1.5× 25 1.2× 24 492
Samuel P. Simons United States 6 234 1.6× 51 0.5× 24 0.7× 13 0.4× 48 2.3× 8 345
Rachel E. Heap United Kingdom 9 209 1.4× 44 0.4× 19 0.5× 63 1.9× 7 0.3× 12 326
Debarati M. Tagore United States 11 329 2.2× 83 0.8× 18 0.5× 52 1.6× 13 0.6× 17 457
Aaron Kempema United States 10 264 1.8× 101 1.0× 39 1.1× 17 0.5× 29 1.4× 15 449
M.G. Gruetter Switzerland 10 220 1.5× 61 0.6× 16 0.5× 15 0.5× 36 1.7× 12 348
Michael J. Bodkin United Kingdom 10 215 1.5× 86 0.9× 11 0.3× 30 0.9× 19 0.9× 18 360
Bjarne Due Larsen Denmark 12 375 2.5× 62 0.6× 18 0.5× 27 0.8× 12 0.6× 26 489

Countries citing papers authored by Christopher A. LeClair

Since Specialization
Citations

This map shows the geographic impact of Christopher A. LeClair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. LeClair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. LeClair more than expected).

Fields of papers citing papers by Christopher A. LeClair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. LeClair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. LeClair. The network helps show where Christopher A. LeClair may publish in the future.

Co-authorship network of co-authors of Christopher A. LeClair

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. LeClair. A scholar is included among the top collaborators of Christopher A. LeClair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. LeClair. Christopher A. LeClair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levine, Max Z., Chandrasekhar Gurramkonda, Dingyin Tao, et al.. (2025). On-demand insulin manufacturing using cell-free systems with an "on-column" conversion approach. New Biotechnology. 89. 51–59. 1 indexed citations
2.
Richard, Ann M., Dingyin Tao, Christopher A. LeClair, et al.. (2024). Analytical Quality Evaluation of the Tox21 Compound Library. Chemical Research in Toxicology. 38(1). 15–41. 4 indexed citations
3.
Kales, Stephen C., Natarajan V. Bhanu, Ying Xiong, et al.. (2023). Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors. ACS Chemical Biology. 18(10). 2249–2258. 4 indexed citations
4.
Ettedgui, Jessica, Natarajan Raju, Samuel A. Kotler, et al.. (2023). Perfluorinated Iridium Catalyst for Signal Amplification by Reversible Exchange Provides Metal-Free Aqueous Hyperpolarized [1-13C]-Pyruvate. Journal of the American Chemical Society. 146(1). 946–953. 12 indexed citations
5.
Levine, Max Z., Lauren R. H. Krumpe, Jennifer A. Wilson, et al.. (2023). An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics. New Biotechnology. 76. 13–22. 6 indexed citations
6.
Yan, Wenjing, Yongwang Zhong, Xin Hu, et al.. (2023). Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. Nature Communications. 14(1). 4798–4798. 16 indexed citations
7.
Fang, Yuhong, Dingyin Tao, Hongmao Sun, et al.. (2022). Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen. ACS Pharmacology & Translational Science. 5(10). 993–1006. 7 indexed citations
8.
Liang, Dongdong, Wenjing Yan, Yongwang Zhong, et al.. (2022). A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase. Molecular Biology of the Cell. 33(13). ar120–ar120. 11 indexed citations
9.
Zhang, Yaqin, Tuan Xu, Zhengxi Wei, et al.. (2021). A Universal and High-Throughput Proteomics Sample Preparation Platform. Analytical Chemistry. 93(24). 8423–8431. 22 indexed citations
10.
Liu, Li, Manshu Tang, Rajan Pragani, et al.. (2021). Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors. Journal of Medicinal Chemistry. 64(18). 13551–13571. 4 indexed citations
11.
Chen, Yu, Carlos A. Tristan, Lu Chen, et al.. (2021). A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nature Methods. 18(5). 528–541. 76 indexed citations
12.
Tao, Dingyin, Miao Xu, Steven Rodems, et al.. (2021). High-throughput protein modification quantitation analysis using intact protein MRM and its application on hENGase inhibitor screening. Talanta. 231. 122384–122384. 4 indexed citations
13.
Wei, Zhengxi, Yuhong Fang, Maya L. Gosztyla, et al.. (2020). A direct peptide reactivity assay using a high-throughput mass spectrometry screening platform for detection of skin sensitizers. Toxicology Letters. 338. 67–77. 11 indexed citations
14.
Tao, Dingyin, William Leister, Wenwei Huang, Asaf Alimardanov, & Christopher A. LeClair. (2019). Facile High-Performance Liquid Chromatography Mass Spectrometry Method for Analysis of Cyclocreatine and Phosphocyclocreatine in Complex Mixtures of Amino Acids. Journal of Agricultural and Food Chemistry. 67(25). 7190–7196. 5 indexed citations
15.
Jiang, Jian‐kang, Min Shen, Christopher A. LeClair, et al.. (2014). A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor. Bioorganic & Medicinal Chemistry Letters. 24(4). 1148–1153. 15 indexed citations
16.
Yuan, Peixiong, Tyson Tragon, Menghang Xia, et al.. (2011). Phosphodiesterase 4 inhibitors enhance sexual pleasure-seeking activity in rodents. Pharmacology Biochemistry and Behavior. 98(3). 349–355. 2 indexed citations
17.
Cardellina, John H., Vicki A. Montgomery, William Leister, et al.. (2011). Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A. ACS Medicinal Chemistry Letters. 2(5). 396–401. 6 indexed citations
18.
LeClair, Christopher A., Matthew B. Boxer, Craig J. Thomas, & David J. Maloney. (2010). Total synthesis of LL-Z1640-2 utilizing a late-stage intramolecular Nozaki–Hiyama–Kishi reaction. Tetrahedron Letters. 51(52). 6852–6855. 24 indexed citations
19.
Skoumbourdis, Amanda P., Christopher A. LeClair, Eduard Stefan, et al.. (2009). Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(13). 3686–3692. 46 indexed citations
20.
McGarvey, Glenn J., et al.. (2008). Studies on the Stereoselective Synthesis of C-Allyl Glycosides. Organic Letters. 10(21). 4727–4730. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026